Literature DB >> 7048944

Endocervical and endometrial adenocarcinoma: an immunoperoxidase and histochemical study.

C Cohen, G Shulman, L R Budgeon.   

Abstract

Carcinoembryonic antigen (CEA) has been demonstrated in endocervical but not in endometrial adenocarcinomas, suggesting a valuable differentiating feature. Using an immunoperoxidase technique for CEA, alcian blue (AB)-periodic acid-Schiff stain for acidic and neutral mucosubstances, respectively, and Mayer's mucicarmine for epithelial mucosubstances, 13 endocervical and 21 endometrial adenocarcinomas were studied to delineate differentiating criteria. CEA was present in all endocervical adenocarcinomas with strongly positive immunostaining in 69%, diffusely throughout the tumor in 77%, intracellularly in 77%, in luminal secretions in 39%, and at the cell surface in 31%. Only 11 (52%) endometrial adenocarcinomas contained CEA, 82% with weak immunostaining, 64% focally, 82% at the cell surface and 36% intracellularly. Mucin was present in 12 (92%) endocervical lesions with AB-positive intracellular and luminal secretion in 83%, strong positivity in 42%, and a diffuse distribution in 60% with all three stains. Moderate or small amounts of mucin were present in 19 (91%) endometrial lesions, focally in 80%, in luminal secretions in 94%, and intracellularly in 42%. Thus, the majority of endocervical adenocarcinomas showed abundant diffusely distributed intracellular CEA and mucin, and mucinous luminal secretions. Half of the endometrial adenocarcinomas contained focal small amounts of apical surface CEA. Mucin was present focally particularly in luminal secretions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7048944     DOI: 10.1097/00000478-198203000-00007

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

Review 1.  Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Sandra Lee; Marianne S Rose; Vikrant V Sahasrabuddhe; Rachel Zhao; Máire A Duggan
Journal:  Int J Gynecol Pathol       Date:  2017-07       Impact factor: 2.762

2.  Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.

Authors:  A Alkushi; J Irving; F Hsu; B Dupuis; C L Liu; M Rijn; C B Gilks
Journal:  Virchows Arch       Date:  2003-02-12       Impact factor: 4.064

3.  Difference in cytoplasmic localization pattern of neutral mucin among lobular endocervical glandular hyperplasia, adenoma malignum, and common adenocarcinoma of the uterine cervix.

Authors:  Isamu Hayashi; Hitoshi Tsuda; Tadakazu Shimoda; Arafumi Maeshima; Takahiro Kasamatsu; Takuro Yamada; Ryuichiro Tsunematsu
Journal:  Virchows Arch       Date:  2003-10-11       Impact factor: 4.064

4.  Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinoma.

Authors:  Thaer Khoury; Dongfeng Tan; Jianmin Wang; Marilyn Intengan; Jun Yang; Sadir Alrawi; Peisha Yan; James C Byrd
Journal:  BMC Clin Pathol       Date:  2006-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.